What are T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL)?
T-ALL and T-LBL are rare, extremely aggressive, and difficult to treat forms of blood cancers involving T-cells. T-cells are a type of cell in the blood that are a part of your immune system. How does ATRIANCE™ work? ATRIANCE™ damages cancer cells, causing their death What are the advantages of ATRIANCE™ over other therapies? Patients with relapsed or refractory T-ALL and T-LBL have limited treatment choices. ATRIANCE™ provides a new option for patients with these diseases. What do patients need to know about using ATRIANCE™? ATRIANCE™ should be given under the supervision of a doctor experienced in the use of anti-cancer medicines. Serious side effects with ATRIANCE™ include: • persistent serious nervous system problems such as tingling or numbness (lack of sensation) in fingers, hands, toes, or feet; difficulty with fine motor coordination tasks such as buttoning clothing; unsteadiness while walking; weakness arising from a low chair; weakness in climbing stairs; increased tripping w
Related Questions
- Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma?
- Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia?
- What are T-cell acute lymphoblastic leukemia (T-ALL) and T-cell lymphoblastic lymphoma (T-LBL)?
